Plague Genome: The Evolution Of a Pathogen

Plague has earned a place in history books as the Black Death of medieval Europe, and in novels, from Albert Camus' classic The Plague, to the more recent Year of Wonders.1,2 A different medium for telling the tale of the plague bacterium Yersinia pestis is its genome, recently sequenced by researchers at the Sanger Centre, the London School of Hygiene and Tropical Medicine, the Royal London School of Medicine and Dentistry, and the Imperial College of Science, Technology and Medicine.3 In addi

Written byRicki Lewis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

In addition to identifying 4,012 genes, comprising 84 percent of the sequence, the work reveals an unusually dynamic genome, with genes added, moved, and silenced into pseudogenehood. "This flexibility in its genome has made Yersinia pestis a finely tuned pathogen that is adaptable to new routes of transmission to humans. This is like watching evolution in action," says Brendan Wren, professor of microbial pathogenesis at the London School of Hygiene and Tropical Medicine.

Clues in the genome support the hypothesis that Y. pestis evolved, 1,500 to 20,000 years ago, from the less fearsome human enteric pathogen Y. pseudotuberculosis. In 1999, researchers from the Max Planck Institute for Molecular Genetics and the Pasteur Institute compared six genes among 36 strains of Y. pestis and 13 of Y. pseudotuberculosis. The near genetic identity of the two types of bacteria suggested that the plague microbe veered onto its own evolutionary pathway.4 Ironically, University ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies